德银研报:礼来口服减重药关键三期试验不及预期 episode artwork

EPISODE · Aug 14, 2025 · 3 MIN

德银研报:礼来口服减重药关键三期试验不及预期

from 左兜进右兜

每周六,周日复盘美股技术及宏观。了解更多财经信息,研报信息,交易逻辑,如内容引起您的共鸣,请订阅我们,以支持我们继续分析创作,谢谢你。8月7日,德意志银行发布最新公司更新研报,维持对礼来(Eli Lilly, LLY)的买入评级,目标价1010美元,但提示短期股价可能承压。原因在于,礼来口服GLP-1减重药Orforglipron(简称Orforg)三期临床ATTAIN-1结果不及市场预期。本期内容:主播左兜儿幕后制作右兜如需获得更多及时研报、英文原文,模型技术研报,模型交易日志,欢迎加入我的知识付费圈子,《左兜进右兜/美股策略》在小宇宙查看该单集文稿

Episode metadata supplied by the publisher feed · Published Aug 14, 2025

Embed this episode

Ready to play

德银研报:礼来口服减重药关键三期试验不及预期

0:00 3:39

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of 左兜进右兜?

This episode is 3 minutes long.

When was this 左兜进右兜 episode published?

This episode was published on August 14, 2025.

Can I download this 左兜进右兜 episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!